Bristol-Myers Squibb Company (NYSE:BMY) Short Interest Update

Marco Green
July 30, 2017

The company's stock had a trading volume of 9,099,647 shares. The institutional investor held 295,715 shares of the plastic products company at the end of 2016Q4, valued at $14.41 million, up from 8,300 at the end of the previous reported quarter. Carl Domino Inc who had been investing in Gilead Sciences Inc for a number of months, seems to be less bullish one the $99.02B market cap company.

In looking at volatility levels, the shares saw weekly volatility of 2.19% and 1.57% over the past month. Exxon Mobil Corporation (NYSE:XOM) has declined 9.08% since July 28, 2016 and is downtrending. It has outperformed by 40.53% the S&P500.

Bristol-Myers Squibb (NYSE:BMY) last issued its quarterly earnings results on Thursday, July 27th. 40 North Management Llc bought 56,971 shares as the company's stock rose 1.36% with the market. The firm had revenue of $5.14 billion for the quarter, compared to analysts' expectations of $5.09 billion.

Bristol-Myers Squibb (NYSE:BMY) last issued its quarterly earnings data on Thursday, July 27th.

At the time of writing, the stock was trading at $55.27.

Shares of Bristol-Myers Squibb (NYSE:BMY) opened at 55.27 on Friday. It has underperformed by 39.89% the S&P500. The Webster Bank holds 970,195 shares with $87.57 million value, down from 1.18 million last quarter.

Investors sentiment decreased to 1.01 in Q4 2016. Its down 0.16, from 1.13 in 2016Q3.

Want to see what other hedge funds are holding BMY? 126 funds opened positions while 468 raised stakes. As of quarter end Strs Ohio had acquired 128,111 shares growing its stake by 8.0%. Parthenon Limited Liability Company reported 10,515 shares. Teacher Retirement Sys Of Texas holds 9,196 shares or 0% of its portfolio. Old Natl Natl Bank In stated it has 130,166 shares. Howe & Rusling Incorporated holds 0% or 238 shares. Currently, 0.5% of the company's shares are sold short. California State Teachers Retirement owns 251,128 shares or 0.02% of their U.S. portfolio. Blackrock Group holds 0.42% or 14.92M shares in its portfolio. Weiss Multi holds 0.11% or 44,999 shares. Campbell Newman Asset Inc holds 35,299 shares or 0.4% of its portfolio. Chicago Equity Ltd Limited Liability Company, a Illinois-based fund reported 291,725 shares. Haverford reported 1.16 million shares. About 6.16M shares traded. Macguire Cheswick And Tuttle Invest Counsel Lc owns 35,685 shares.

Sell-side analysts are offering a consensus "Buy" rating on shares of IDEXX Laboratories, Inc. Therefore 100% are positive. The institutional investor held 650,000 shares of the prepackaged software company at the end of 2016Q4, valued at $30.08 million, up from 593,029 at the end of the previous reported quarter. Deutsche Bank maintained the shares of BERY in report on Wednesday, November 18 with "Buy" rating. The rating was maintained by Cantor Fitzgerald with "Buy" on Monday, June 5. September 12 investment analysts at Jefferies left the company rating at "Equal-weight" and moved down the price target from $80.00 to $65.00. UBS has "Buy" rating and $70 target. As per Wednesday, July 13, the company rating was initiated by SunTrust. The company was maintained on Monday, May 2 by Credit Suisse. Robert W. Baird initiated the shares of BMY in report on Wednesday, April 26 with "Outperform" rating. Goldman Sachs downgraded Berry Global Group Inc (NYSE:BERY) on Monday, August 3 to "Neutral" rating. On Monday, July 17 the stock rating was maintained by Jefferies with "Buy".

The company recently announced a dividend for shareholders that will be paid on Tuesday the 1st of August 2017. Q2 Profit Falls 19%" on July 26, 2017, also with their article: "Gilead Sciences: "The Biggest of Beats?" published on July 27, 2017, published: "1 Chart Speaks Volumes About Gilead Sciences' Future" on July 28, 2017.

40 North Management Llc increased its stake in Ptc Inc (PTC) by 9.61% based on its latest 2016Q4 regulatory filing with the SEC.

More notable recent Bristol-Myers Squibb Co (NYSE:BMY) news were published by: which released: "Hardesty Capital Management Corp Buys Bristol-Myers Squibb Company, Helmerich ..." on July 28, 2017, also with their article: "Bristol-Myers Squibb: Strong Fundamentals Suggest Shares Are Undervalued" published on July 10, 2017, published: "Bridges Investment Management Inc Buys Bristol-Myers Squibb Company, Bristol ..." on July 21, 2017.

Bristol-Myers Squibb Company (NYSE BMY) traded up 1.90% during mid-day trading on Friday, reaching $55.27.

Since February 27, 2017, it had 1 buy, and 6 selling transactions for $9.91 million activity. The insider LEUNG SANDRA sold 92,405 shares worth $5.27 million. OLD National Bancorp IN's holdings in Bristol-Myers Squibb were worth $4,790,000 at the end of the most recent reporting period. This is not a recommendation to buy or sell Bristol-Myers Squibb Company (NYSE:BMY). Therefore 32% are positive. Rothschild Investment Il owns 0.5% invested in Bristol-Myers Squibb Co (NYSE:BMY) for 71,571 shares.

Harwood Advisory Group LLC reduced its stake in Bristol-Myers Squibb Company (NYSE:BMY) by 7.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm has "Equal-Weight" rating given on Friday, August 5 by Morgan Stanley. Bristol-Myers Squibb has a 1-year low of $46.01 and a 1-year high of $76.30. This rating was disclosed in an analyst note on Friday morning. BMO Capital Markets lowered shares of Bristol-Myers Squibb from a "market perform" rating to an "underperform" rating and set a $47.00 price target on the a research report on Wednesday, May 3rd.

Other reports by Click Lancashire

Discuss This Article